| abstract |
Disorders that can be treated by stimulating or increasing telomerase expression, activity or combinations thereof in cells or tissues and selected from macular degeneration and other retinal diseases, as well as osteoporosis and other degenerative joint diseases Of a compound for the manufacture of a pharmaceutical composition for use in the treatment of. Formula IV Use of a compound represented by a structure such as (R1, R3, R4, R6, R7 and R9 are the same or different and are H or Br; and R10 is methyl). [Selection] Figure 1 |